Canada's pharmaceutical firms reversed a decade-long slide in R&D intensity in 2007, with a $115-million spike in expenditures that pushed the annual total up 9.8% to $1.274 billion. The upswing was accompanied by a 7.
... Please become a Member or login to read the rest of this article ...
Other stories mentioning these organizations, people and topics
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively
in accordance with our Privacy Policy and Terms of Service.